Mesothelioma in Situ of the Spermatic Cord Arising from a Patent Processus Vaginalis: A Case Report
5 January 2019
Mesothelioma is an aggressive tumor originating from mesothelial cells. Mesothelioma of the spermatic cord is a very rare disease, and the most common presentation of this disease is that of aggressive mesothelioma with no description of mesothelioma in situ. We report an extremely rare case of mesothelioma in situ of the spermatic cord arising from a patent processus vaginalis. To our best knowledge, this is the first report of this finding. The identification of a patent processus vaginalis and investigation of single-layered atypical mesothelial cells led to the final diagnosis.
- atypical mesothelial cells
- mesothelioma in situ
- radical orchiectomy
- spermatic cord tumor
Gemba K, Fujimoto N, Kato K, et al. National survey of malignant mesothelioma and asbestos exposure in Japan. Cancer Sci. 2012;103:483-90.
Kozlowski H, Zoltowska A. Mesothelioma of spermatic cord. Neoplasma. 1968;15:97-100.
Arlen M, Grabstald H, Whitmore WF Jr. Malignant tumors of the spermatic cord. Cancer. 1969;23:525-32.
Pizzolato P, Lamberty J. Mesothelioma of spermatic cord: electron microscopic and histochemical characteristics of its mucopolysaccharides. Urology. 1976;8:403-8.
Leiber C, Katzenwadel A, Popken G, Kersten A, Schultze-Seemann W. Tumour of the spermatic cord: an unusual primary manifestation of an epithelial mesothelioma of the peritoneum with patent processus vaginalis. BJU Int. 2000;86:142-3.
Torbati PM, Parvin M, Ziaee SA. Malignant mesothelioma of the spermatic cord: case report and review of the literature. Urol J. 2005;2:115-7.
Park YJ, Kong HJ, Jang HC, Shin HS, Oh HK, Park JS. Malignant mesothelioma of the spermatic cord. Korean J Urol. 2011;52:225-9.
Meng X, Guzzo TJ, Bing Z. Malignant mesotheliomas in spermatic cords: reports of two cases and a brief review of literature. Rare Tumors. 2013;26:5:e4.
D'Antonio A, Mastella F, Colucci A, Silvestre G. Malignant mesothelioma of spermatic cord in an elderly man with a history of asbestos exposure. Urology. 2016;87:e1-3.
Ahmed Z, Singh S, Mangal A, Mittal A. Primary malignant mesothelioma of the spermatic cord. BMJ Case Rep. 2016; pii: bcr2016214602.
Kinoshita Y, Hida T, Hamasaki M, et al. A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma. Cancer. 2018;126:54-63.
Wu D, Hiroshima K, Yusa T, et al. Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma. Ann Diagn Pathol. 2017;26:31-7.
Churg A, Hwang H, Tan L, et al. Malignant mesothelioma in situ. Histopathology. 2018;72:1033-8.
- Abstract Viewed: 0 times
- Just Accepted/5421 Downloaded: 0 times